Azmat Sadozye

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 89 citations

Gynecological Surgery, Medicine, Metronomic Therapy +6

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Ignace Vergote, Els Van Nieuwenhuysen, Roisin E. O’Cearbhaill et al. · Journal of Clinical Oncology · 2023 · 71 citations · Full text

Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study

Tufve Nyholm, Joakim Jönsson, Karin Söderström et al. · Radiation Oncology · 2013 · 46 citations · Full text

The influence of MRI scan position on image registration accuracy, target delineation and calculated dose in prostatic radiotherapy

Scott Hanvey, Azmat Sadozye, M. McJury et al. · British Journal of Radiology · 2012 · 45 citations · Full text

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 43 citations · Full text